| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 43,015,586 | 46,695,349 | 42,092,484 | | Cost of Revenue | 25,509,931 | 27,144,074 | 23,754,838 | | | Gross Profit | 17,505,655 | 19,551,275 | 18,337,647 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 2,390,851 | 1,416,930 | 1,151,302 | | Non Recurring | (912,076) | 609,781 | (18,484) | | Others | 8,325,688 | 9,034,769 | 7,385,758 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 7,701,191 | 8,489,796 | 9,819,071 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (407,403) | 986,843 | (1,769,202) | | Earnings Before Interest And Taxes | 7,384,009 | 9,603,308 | 8,049,869 | | Interest Expense | 3,300,108 | 3,562,945 | 3,286,227 | | Income Before Tax | 4,083,901 | 6,040,363 | 4,763,642 | | Income Tax Expense | 920,534 | 2,477,418 | 2,501,969 | | Minority Interest |
-
|
-
| 48,851 | | | | Net Income From Continuing Ops | 3,163,367 | 3,562,945 | 2,310,525 | | | Non-recurring Events | | Discontinued Operations | (40,881) | 53,024 | 147,874 | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 3,122,486 | 3,615,970 | 2,458,399 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $3,122,486 | $3,615,970 | $2,458,399 |
|
0.02% Nasdaq 0.00%
Income Statement
